New injection shows promise for debilitating skin itch

NCT ID NCT04183335

Completed Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study tested whether dupilumab, an injectable medication, could help adults with prurigo nodularis, a skin condition causing intense itch and thick bumps. The trial involved 151 people whose condition was not controlled by standard prescription creams. Participants received either dupilumab or a placebo for 24 weeks to see if the drug could significantly reduce itch and improve skin lesions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Investigational Site Number :0320001

Buenos Aires, C1121ABE, Argentina
Investigational Site Number :0320002

CABA, Buenos Aires, C1425BEN, Argentina
Investigational Site Number :0320003

San Miguel de Tucumán, Tucumán Province, T4000AXL, Argentina
Investigational Site Number :0320004

CABA, Buenos Aires F.D., C1425BEA, Argentina
Investigational Site Number :0320005

CABA, Buenos Aires, C1055AAO, Argentina
Investigational Site Number :0320006

Caba, 1425DES, Argentina
Investigational Site Number :0320007

CABA, Buenos Aires F.D., C1431EKK, Argentina
Investigational Site Number :0320008

CABA, Buenos Aires, C1023AAB, Argentina
Investigational Site Number :0320009

Mendoza, M5500, Argentina
Investigational Site Number :1560001

Chengdu, 610041, China
Investigational Site Number :1560002

Hangzhou, 310006, China
Investigational Site Number :1560003

Wuxi, 214002, China
Investigational Site Number :1560004

Beijing, 100050, China
Investigational Site Number :2500005

Reims, 51100, France
Investigational Site Number :3920001

Shinagawa-Ku, Tokyo, 141-8625, Japan
Investigational Site Number :3920002

Nagoya, 454-8509, Japan
Investigational Site Number :3920003

Tokorozawa-shi, Saitama, 359-8513, Japan
Investigational Site Number :3920004

Bunkyo-ku, Tokyo, 113-8519, Japan
Investigational Site Number :3920005

Kyoto, Kyoto, 606-8507, Japan
Investigational Site Number :3920006

Itabashi-ku, Tokyo, 173-8610, Japan
Investigational Site Number :3920007

Nagasaki, Nagasaki, 852-8501, Japan
Investigational Site Number :3920009

Yokohama, Kanagawa, 236-0004, Japan
Investigational Site Number :3920010

Izumo-shi, Shimane, 693-8501, Japan
Investigational Site Number :4100001

Incheon, 21565, South Korea
Investigational Site Number :4100002

Seoul, Seoul-teukbyeolsi, 03080, South Korea
Investigational Site Number :4100003

Seoul, Seoul-teukbyeolsi, 03722, South Korea
Investigational Site Number :4100004

Seoul, Seoul-teukbyeolsi, 07441, South Korea
Investigational Site Number :4100005

Incheon, Incheon-gwangyeoksi, 21431, South Korea
Investigational Site Number :4100007

Seongnam-si, Gyeonggi-do, 13620, South Korea
Investigational Site Number :4840001

Monterrey, Nuevo León, 64460, Mexico
Investigational Site Number :4840002

Guadalajara, Jalisco, 44100, Mexico
Investigational Site Number :4840003

Veracruz, 91910, Mexico
Investigational Site Number :4840005

Monterrey, Nuevo León, 64718, Mexico
Investigational Site Number :4840006

Guadalajara, 44210, Mexico
Investigational Site Number :6430001

Stavropol, 355030, Russia
Investigational Site Number :6430002

Saint Petersburg, 197022, Russia
Investigational Site Number :6430005

Moscow, 107076, Russia
Investigational Site Number :6430006

Moscow, 125993, Russia
Investigational Site Number :6430007

Krasnodar, 350020, Russia
Investigational Site Number :6430008

Chelyabinsk, 454048, Russia
Investigational Site Number :6430009

Saratov, 410026, Russia
Investigational Site Number :6430010

Moscow, 115522, Russia
Investigational Site Number :8400001

Dublin, Ohio, 43016, United States
Investigational Site Number :8400002

Pflugerville, Texas, 78660, United States
Investigational Site Number :8400003

Newnan, Georgia, 30263, United States
Investigational Site Number :8400004

Columbus, Georgia, 31904, United States
Investigational Site Number :8400005

Norfolk, Virginia, 23502, United States
Investigational Site Number :8400006

Bellaire, Texas, 77401, United States
Investigational Site Number :8400007

Tulsa, Oklahoma, 74136, United States
Investigational Site Number :8400009

Athens, Ohio, 45701, United States
Investigational Site Number :8400010

Philadelphia, Pennsylvania, 19104, United States
Investigational Site Number :8400011

Gilbert, Arizona, 85234, United States
Investigational Site Number :8400013

St Louis, Missouri, 63110, United States
Investigational Site Number :8400014

Miami, Florida, 33136, United States
Investigational Site Number :8400015

Charleston, South Carolina, 29414, United States
Investigational Site Number :8400016

Indianapolis, Indiana, 46250, United States
Investigational Site Number :8400017

Sandy Springs, Georgia, 30328, United States
Investigational Site Number :8400018

Clarkston, Michigan, 48346, United States
Investigational Site Number :8400019

San Antonio, Texas, 78249, United States
Investigational Site Number :8400022

Fort Smith, Arkansas, 72916, United States
Investigational Site Number :8400024

East Windsor, New Jersey, 08520, United States
Investigational Site Number :8400025

Houston, Texas, 77058, United States
Investigational Site Number :8400026

Sacramento, California, 95816, United States

Conditions

Explore the condition pages connected to this study.

NEURODERMATITIS